Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy

In daily practice, clinicians are often confronted with obese type 2 diabetes mellitus (T2DM) patients for whom the treatment plan fails and who show an inadequate glycemic control and/or no sustainable weight loss. Untreated hypogonadism can be the reason for such treatment failure.

This case describes the profound impact testosterone therapy can have on a male hypogonadal patient with metabolic syndrome, resulting in a substantial and sustained loss of body weight, pronounced improvement of all critical laboratory values and finally complete remission of diabetes.

See our study report: https://www.nebido.com/hcp/testosterone-news-resources/research-news/remission-of-type-2-diabetes-in-a-hypogonadal-man-after-long-term-testosterone-therapy